John Dobak, a life sciences serial entrepreneur in San Diego, said a new startup he’s leading has raised $2.66 million to advance a drug that is already approved to shrink varicose veins through early-stage clinical trials testing it in a new use -fat reduction body sculpting.
The biotech, 10xBio, announced earlier this month that the FDA had approved its application to begin clinical trials in Phase 1b/2a studies testing the unnamed injectable drug. “We’ve already dosed patients,” Dobak said Tuesday. The studies are intended to establish the safety and tissue responses of the injectable drug, said Dobak, who is the chairman… Read more »
UNDERWRITERS AND PARTNERS